e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
Clinical reviews of the ERS's 20th Anniversary Year: asthma, lung cancer, interstitial lung disease and pulmonary hypertension
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Lung cancer
J-P. Sculier (Brussels, Belgium)
Source:
Annual Congress 2010 - Clinical reviews of the ERS's 20th Anniversary Year: asthma, lung cancer, interstitial lung disease and pulmonary hypertension
Session:
Clinical reviews of the ERS's 20th Anniversary Year: asthma, lung cancer, interstitial lung disease and pulmonary hypertension
Session type:
Hot topics
Number:
3796
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J-P. Sculier (Brussels, Belgium). Lung cancer. Annual Congress 2010 - Clinical reviews of the ERS's 20th Anniversary Year: asthma, lung cancer, interstitial lung disease and pulmonary hypertension
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
Lung ultrasound
Source: Annual Congress 2011 - PG4 Functional lung imaging to describe regional lung function disturbances
Year: 2011
Lung cancer
Source: Breathe 2016; 12: 392-399
Year: 2016
Lung cancer
Source: School Course 2014 - Pulmonary Rehabilitation
Year: 2014
Lung cancer
Source: Virtual Congress 2020 – Impact in children and in adults with premorbid respiratory disease (acute and long-term)
Year: 2020
Breath biomarkers of lung cancer and other diseases
Source: Annual Congress 2010 - Advances on breath monitoring of inflammatory airway disease
Year: 2010
Improvements in lung cancer surgery
Source: Annual Congress 2011 - Surgery for lung cancer: pre-operative evaluation and results
Year: 2011
Biomarkers for lung cancer screening
Source: Annual Congress 2011 - PG20 Biomarkers in respiratory medicine
Year: 2011
Indolent lung cancers
Source: Annual Congress 2011 - Slow-growing lung cancer
Year: 2011
Symptom-to-treatment intervals in lung cancer
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014
Lung cancer and other ILDs
Source: Research Seminar 2015
Year: 2015
Lung cancer in ILDs
Source: School Course 2014 - Interstitial lung diseases
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept